These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 1231459
21. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors]. Oelz O. Schweiz Med Wochenschr; 1979 Mar 10; 109(10):348-53. PubMed ID: 424707 [Abstract] [Full Text] [Related]
22. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use]. Croveri G. Minerva Cardioangiol; 1980 Oct 10; 28(10):723-6. PubMed ID: 7465066 [No Abstract] [Full Text] [Related]
23. [Present situation of therapy with platelet aggregation inhibitors]. Poliwoda H. Acta Med Austriaca Suppl; 1982 Oct 10; 25():55-61. PubMed ID: 6958157 [No Abstract] [Full Text] [Related]
24. [Mode of action and clinical evaluation of platelet aggregation inhibitors]. David JL. Rev Med Liege; 1987 May 15; 42(10):526-33. PubMed ID: 3616303 [No Abstract] [Full Text] [Related]
25. Antiplatelet therapy. Sloan RW. Am Fam Physician; 1981 Oct 15; 24(4):129-34. PubMed ID: 7025599 [Abstract] [Full Text] [Related]
26. [Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease]. Gryglik J. Pol Tyg Lek; 1979 Mar 26; 34(13):509-11. PubMed ID: 375209 [No Abstract] [Full Text] [Related]
31. [Thrombocyte aggregation inhibitors--a new class of active substances. 2. Chemical and pharmacologic aspects of some agents]. Böhm R. Pharmazie; 1986 Feb 26; 41(2):81-7. PubMed ID: 3523547 [No Abstract] [Full Text] [Related]
33. Assessment of antithrombotic drugs ex vivo and in vivo. Buchanan M, Hirsh J. Bibl Anat; 1977 Jun 26; (16 Pt 2):208-11. PubMed ID: 603518 [No Abstract] [Full Text] [Related]
37. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man. Lorenz R, Siess W, Weber PC. Eur J Pharmacol; 1981 Apr 09; 70(4):511-8. PubMed ID: 7238575 [Abstract] [Full Text] [Related]
38. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs. Buchanan M, Hirsh J. Thromb Diath Haemorrh; 1975 Nov 15; 34(2):552. PubMed ID: 1198423 [No Abstract] [Full Text] [Related]
39. Antiplatelet aggregators inhibit development of stress ulcers in Sprague-Dawley rats. Kumashiro R, Piotrowski JJ, Kholoussy AM, Hashimoto N, Matsumoto T. Eur Surg Res; 1985 Nov 15; 17(1):44-52. PubMed ID: 3972005 [Abstract] [Full Text] [Related]
40. Inhibitors of immune complex induced human platelet aggregation and release in plasma. Clark WF, Tevaarwerk GJ, Moriarity TA, Reid BD. Thromb Res; 1982 Dec 01; 28(5):681-8. PubMed ID: 7167877 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]